Insights from Digital Pharma Leaders
Refine search
Pharmaceutical
British pharma major AstraZeneca is expanding its oncology-focused artificial intelligence collaboration with US biotech Immunai in a deal that could bring the smaller company up to $37.5 million over 2026-2027. 8 May 2026
Pharmaceutical
Ahead of a London event on May 12 on how AI is rapidly reshaping how healthcare information is discovered, interpreted and shared, this week's Expert View comes from panellist Sophie Randall, Director of the Patient Information Forum, the UK membership organization for people working in health information and support. 6 May 2026
Biotechnology
Profluent, the frontier AI company pioneering large-scale foundation models for protein design, today announced a multi-program strategic research collaboration with Eli Lilly to develop and commercialize custom site-specific recombinases to address diseases with severe unmet needs. 28 April 2026
Biotechnology
Belgian drugmaker UCB and the University of Southampton have announced a joint three-year project that they have dubbed the Digital Antibody Research Collaboration (DARC). 27 April 2026
Pharmaceutical
Merck & Co and Google Cloud have announced a landmark partnership to enhance the US pharma giant’s digital backbone as an AI-enabled enterprise. 23 April 2026
Biotechnology
This week on The Pharma Letter Podcast, we’re joined by Kenneth Mulvany, founder and executive chair of BenevolentAI: one of the UK’s earliest and most high-profile attempts to apply machine learning to drug discovery. 23 April 2026
Biotechnology
US biotech major Amgen has announced the retirement of David Reese, executive vice president and chief technology officer, effective June 30. 23 April 2026
Biotechnology
US biotech Elephas Biosciences has entered a research collaboration with artificial intelligence firm Mithrl, aiming to combine real-time tumor profiling with automated data analysis to better understand responses to immunotherapy. 17 April 2026
Pharmaceutical
Ryght AI, a provider of real-time generative AI solutions for the clinical research industry, has announced the launch of RyghtSites.com.
The free, publicly accessible tool allows pharmaceutical companies and Contract Research Organizations (CROs) to instantly search, rank, and download lists of the world's best clinical research sites for your search. 17 April 2026
Biotechnology
German innovation hub BioMed X has launched its first research team in France, partnering with French pharma Servier to advance AI-driven antibody engineering at the Paris-Saclay campus. 16 April 2026
Pharmaceutical
Novo Nordisk has announced a strategic partnership with OpenAI, the US AI research and deployment company. 14 April 2026
Biotechnology
Japanese drugmaker Daiichi Sankyo is deepening its push into AI-driven oncology, partnering with USA-based Imagene AI to advance biomarker discovery and response prediction across its cancer pipeline. 10 April 2026
Pharmaceutical
Tempus AI , a technology company leading the adoption of AI to advance precision medicine, has announced an expanded, multi-year collaboration with Gilead Sciences aimed at building and advancing Gilead’s oncology pipeline. 10 April 2026
Biotechnology
Syneron Bio, a China based leader in intelligent platform-driven macrocyclic peptide drug discovery, announced the successful closing of its Series B financing on March 31. The news comes less than four months after Syneron closed its Series A and A+ rounds at close to $100 million in total. 7 April 2026
Biotechnology
French biotech company Transgene , which develops virus-based immunotherapies for the treatment of cancer, and NEC Bio, a wholly owned subsidiary of NEC Corporation, a leader in IT, network and AI technologies, have signed a license agreement to advance the clinical development of TG4050, an individualized neoantigen therapeutic vaccine (INTV) in the adjuvant treatment of resected HPV-negative head and neck cancer. s 3 April 2026
Biotechnology
OpenProtein.AI, a US firm that calls itself a leader in AI-powered protein engineering software, has announced an expansion of its partnership with privately-held German drugmaker Boehringer Ingelheim to co-develop specialized antibody discovery and optimization workflows. 1 April 2026
Pharmaceutical
Swiss neurotech firm MindMaze Therapeutics and US provider Vibra Healthcare have reported real-world evidence suggesting technology-enabled, high-dose therapy can improve recovery outcomes for stroke patients in inpatient rehabilitation. 31 March 2026
Pharmaceutical
Honk Kong-based Insilico Medicine has announced a drug discovery collaboration with US pharma major Eli Lilly that uses Insilico’s AI engine to accelerate the discovery and development of novel therapeutics across multiple therapeutic areas. 30 March 2026
Biotechnology
US biotech Pinnacle Medicines, which is pioneering the development of oral peptide therapeutics using proprietary AI and physics-based platforms, today announced the closing of an oversubscribed $89 million Series B financing. 26 March 2026
Pharmaceutical
Israel-based Purple Biotech today announced a collaboration with Converge Bio, a company known for its leading AI platform for drug discovery and development, to accelerate and enhance Purple Biotech's next-generation tri-specific antibody platform leveraging advanced generative AI capabilities. 26 March 2026
Biotechnology
Firms with an interest in artificial intelligence (AI), such as Microsoft and Nvidia, led US stock markets to new heights last year, as investors sought to price in imagined productivity gains from new AI technologies. 15 March 2024
Pharmaceutical
German firms Bayer and Aignostics have announced a strategic collaboration on several artificial intelligence (AI)-powered approaches with applications in precision oncology drug research and development. 14 March 2024
Pharmaceutical
Germany-based AI-driven drug discovery company Partex Group has announced a collaboration with French pharma major Sanofi. 14 March 2024
Pharmaceutical
Japanese drugmaker Shionogi says it has submitted a marketing approval application for the digital therapeutic app SDT-001, for commercialization and sale in Japan. 27 February 2024
Biotechnology
As in other industries, enthusiasm for artificial intelligence (AI)-based technologies shows no sign of abating in the life sciences. 25 January 2024
Pharmaceutical
AI company Isomorphic Labs has announced strategic collaborations with two of the world’s leading pharma firms, Eli Lilly and Novartis. 8 January 2024
Biotechnology
The life sciences landscape has adapted in tandem with data management solutions over the past several years, attracting significant investment. However, these solutions lack the ability to rapidly address and complement existing pain points and previous investments with the latest technological innovations. 3 January 2024
Biotechnology
A new collaboration between Washington, USA-based Absci and UK-based AstraZeneca will see the firms working together to discover new cancer treatments. 4 December 2023
Pharmaceutical
A new artificial intelligence (AI)-based model developed by scientists at ETH Zurich could help determine optimal synthesis methods for new active pharmaceutical ingredients (API). 27 November 2023
Pharmaceutical
Nobody could call it a good week for Bayer, with its shares slumping to their lowest level in a decade on Monday after the firm said it would discontinue a Phase III trial for a blood-thinning drug for heart disease that had failed to demonstrate efficacy. 23 November 2023
Pharmaceutical
The UK’s largest drugmaker, AstraZeneca, has announced the launch of a new AI-focused digital health solutions company, to be called Evinova. 20 November 2023
Pharmaceutical
Spanish dermatology specialist Almirall and US generative AI drug creation company Absci Corporation have announced a drug discovery partnership. 14 November 2023
Pharmaceutical
Germany’s Bayer and Recursion Pharmaceuticals, a US techbio firm seeking to decode biology to industrialize drug discovery, have updated the focus of their research collaboration to precision oncology. 10 November 2023
Pharmaceutical
Life science compliance specialist Model N has announced product enhancements relating to the Inflation Reduction Act. 8 November 2023
Biotechnology
French venture capital firm Sofinnova Partners has announced the closing of a $200 million fund, spearheaded by partners Edward Kliphuis and Simon Turner. 27 October 2023
Biotechnology
As drugmakers around the world rush to embrace the potential of artificial intelligence (AI) in the design and development of new medications, the World Health Organization has urged caution. 23 October 2023
Pharmaceutical
On Wednesday, the US Food and Drug Administration (FDA) announced the creation of a new Digital Health Advisory Committee. 12 October 2023
Biotechnology
A company founded by Flagship Pioneering, Generate Biomedicines, has raised over a quarter of a billion dollars in a series C financing round. 14 September 2023
Biotechnology
Japanese mid-size drugmaker Otsuka Pharmaceutical has inked a deal with ShapeTX, a specialist in programmable medicines. 8 September 2023
Pharmaceutical
A new report from British market research firm Deep Pharma Intelligence provides a profile of the use of artificial intelligence in the drug discovery industry. 17 August 2023
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2026
| Headless Content Management with Blaze